‘Modelling the potential economic impact of viral-load driven triple drug combination antiretroviral therapy’, PharmacoEconomics, vol. 13, pp. 697–705.

Bardsley P & Olekalns N 1999, ‘Cigarette and tobacco consumption: have anti-smoking policies made a difference?’, Economic Record, vol. 75, pp. 225–40.

Beenstock M & Gafni D 2000, ‘Globalisation in road safety: explaining the downward trend in road

accident rates in a single country (Israel)’, Accident Analysis and Prevention, vol. 32, pp. 71–84.

Economic Evaluation of Aspects of the Australian HIV/AIDS Strategies, Australian Government Publishing Service, Canberra.

Chapman S 2000, ‘Commentary: if you can’t count it ... it doesn’t count: the poverty of econometrics in explaining complex social and behavioural change’, mimeo, Department of Public Health and Community Medicine, University of Sydney.

Cutler DM & Richardson E 1997, ‘Measuring the health of the U.S. Population’, Brookings Paper on Economic Activity, Microeconomics, Brookings Institute, Washington, DC.

Feachem RG 1995, Valuing the Past ... Investing in the Future: Evaluation of the National HIV/AIDS

Hurley SF, Kaldor JM, Gardiner S, Carlin JB, Assuncao RM, Evans DB 1996b, ‘Lifetime cost of human immunodeficiency virus-related health care’, Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, vol. 12, pp. 371–8.

Marschner LC & Watson LF 1994, ‘An improved EMS algorithm for back-projection of AIDS incidence data’, Journal of Statistical Computation and Simulation, vol 50, pp. 1–20.

Mast E, Berg J, Hanrahan L, Wassell J, Davis J 1990, “Risk factors for measles in a previously vaccinated population and cost effectiveness of revaccination strategies’, Journal of the American Medical Association, vol. 264, pp. 2529–33.

Mathers C, Penm R, Sanson-Fisher R, Carter R, Campbell E 1998a, Health Costs of Cancer in Australia 1993–94, AIHW, cat. no. HWE 8, Canberra.

Mathers C, Stevenson C, Carter R, Penm R 1998b, Disease Costing Methodology Used in the Disease Costs and Impacts Study 1993–94, AIHW, cat. no. HWE 7, Canberra.

Mathers C & Penm R 1999a, Health system costs of cardiovascular diseases and diabetes in Australia 1993–94, cat. no. HWE 11, AIHW, Canberra.

Mathers C & Penm R 1999b, Health System Costs of Injury, Poisoning and Musculoskeletal Disorders in Australia 1993–94, cat. no. HWE 12, AIHW, Canberra.

Mathers C, Vos T, Stevenson C 1999, The Burden of Disease and Injury in Australia, cat. no. PHE 18, AIHW, Canberra.

Moore RD 2000, ‘Cost effectiveness of combination HIV therapy: 3 years later’, PharmacoEconomics, vol. 17, pp. 325–30.

Murphy KM & Topel R 1999, The Economic Value of Medical Research, 1999, University of Chicago Business School, mimeo.

Newstead S, Cameron M, Gantzer S, Vulcan P 1995, ‘Modelling some of the Major Factors Influencing Road Trauma Trends in Victoria, 1989–93’, Monash University Accident Research Centre, Report No.74, Melbourne.

Pinkerton SD & Holtgrave DR 1999, ‘Economic impact of delaying or preventing AIDS in persons with HIV’, American Journal of Managed Care, vol. 5, no. 3, pp. 289–98.

Shiell A, Jorm L, Carruthers R, Fitzsimmons G 1998, “Cost-effectiveness of measles outbreak intervention strategies’. Australia New Zealand Journal of Public Health, vol. 22, pp 126–32.

Thacker S & Millar J 1991, ‘Mathematical modelling and attempts to eliminate measles: a tribute to the late Professor George Macdonald’, Am J Epidemiol, vol. 133, pp. 517–25.

Tolley GS, Kenkel DS, Fabian RG (eds) 1994, Valuing Health for Policy: An Economic Approach, University of Chicago Press, Chicago.

Viscusi WK 1993, ‘The value of risks to life and health’, Journal of Economic Literature, vol. 31, pp.1912–46.

Wang B, Hensher DA, Ton T 1999, ‘Modelling Road Safety Trends and Predicting Road Fatalities in Australia’, Institute of Transport Studies, Working Paper 99–7, Sydney.